No price history available.
Key financial summary
Financials in SEK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | SEKm | 121,752 | 121,867 | 156,173 | 147,147 | 145,546 | 138,494 | N/A | N/A |
| Operating profit | SEKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | SEKm | 10,228 | 8,620 | 5,567 | 9,554 | 20,888 | 12,656 | N/A | N/A |
| EPS reported | SEK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | SEK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | SEK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | SEK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | SEKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | SEKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | SEKm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | SEK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | SEK | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in SEK| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Essity AB (publ) is a global manufacturer and distributor of personal care and wellness goods, along with related services. Its portfolio encompasses medical and healthcare items such as incontinence management solutions, wound care treatments, compression wear, orthopedic supports, skincare formulations, and advanced digital health tools featuring sensor technology. The company organizes its business into several divisions: Personal Care, Consumer Tissue, Professional Hygiene, and various other operations. Essity also manufactures a wide array of consumer products, including absorbent items (pads, diapers, washable absorbent underwear, menstrual cups, incontinence products), personal care items (wet wipes, skincare, intimate soaps), and paper goods (toilet papers, household towels, handkerchiefs, facial tissues, napkins). For professional settings, its hygiene offerings include restroom essentials (toilet papers, paper hand towels, napkins), hand care (soaps, lotions, sanitizers), dispensing systems, and cleaning/wiping solutions. Furthermore, the firm delivers digital innovations, particularly Internet of Things (IoT) sensor technology designed for data-driven facility management, alongside associated service and maintenance. These solutions cater to a diverse clientele, including corporate offices, educational institutions, healthcare providers, industrial sites, food service establishments, hospitality venues, sports arenas, and various other public spaces. Its medical and healthcare product lines, sold under brand names such as TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Cast, reach consumers through a variety of channels, including pharmacies, specialized medical device retailers, hospitals, authorized distributors, care facilities, and online platforms. Consumer products, featuring brands like Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda, are available via retail outlets and e-commerce. Professional hygiene items, branded as TORK, are distributed through intermediaries and digital storefronts. Essity's market presence extends across Europe, North America, Latin America, Asia, and other international regions. Established in 1849, Essity AB (publ) maintains its headquarters in Stockholm, Sweden.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Essity AB (publ) (ESSITY-B.ST)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Essity AB (publ) is a global manufacturer and distributor of personal care and wellness goods, along with related services. Its portfolio encompasses medical and healthcare items such as incontinence management solutions, wound care treatments, compression wear, orthopedic supports, skincare formulations, and advanced digital health tools featuring sensor technology. The company organizes its business into several divisions: Personal Care, Consumer Tissue, Professional Hygiene, and various other operations. Essity also manufactures a wide array of consumer products, including absorbent items (pads, diapers, washable absorbent underwear, menstrual cups, incontinence products), personal care items (wet wipes, skincare, intimate soaps), and paper goods (toilet papers, household towels, handkerchiefs, facial tissues, napkins). For professional settings, its hygiene offerings include restroom essentials (toilet papers, paper hand towels, napkins), hand care (soaps, lotions, sanitizers), dispensing systems, and cleaning/wiping solutions. Furthermore, the firm delivers digital innovations, particularly Internet of Things (IoT) sensor technology designed for data-driven facility management, alongside associated service and maintenance. These solutions cater to a diverse clientele, including corporate offices, educational institutions, healthcare providers, industrial sites, food service establishments, hospitality venues, sports arenas, and various other public spaces. Its medical and healthcare product lines, sold under brand names such as TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Cast, reach consumers through a variety of channels, including pharmacies, specialized medical device retailers, hospitals, authorized distributors, care facilities, and online platforms. Consumer products, featuring brands like Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda, are available via retail outlets and e-commerce. Professional hygiene items, branded as TORK, are distributed through intermediaries and digital storefronts. Essity's market presence extends across Europe, North America, Latin America, Asia, and other international regions. Established in 1849, Essity AB (publ) maintains its headquarters in Stockholm, Sweden.
